SureTrader
Home > Boards > US Listed > Medical - Drugs > Valeant Pharmaceuticals International (VRX)

Agree, it's not orderly,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
JLS Member Profile
 
Followed By 49
Posts 6,279
Boards Moderated 0
Alias Born 12/14/04
160x600 placeholder
Ortho Dermatologics Presents An Analysis Of SILIQ™ (Brodalumab) Injection Phase 3 Data On Disease-Related Anxiety And Depre... PR Newswire (Canada) - 2/16/2018 10:00:00 AM
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For JEMDEL™ Plaque Psoriasis Treatment PR Newswire (Canada) - 2/14/2018 7:00:00 AM
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For JEMDEL™ Plaque Psoriasis Treatment PR Newswire (US) - 2/14/2018 7:00:00 AM
Salix Provides Update on FDA Submission for PLENVU®* PR Newswire (Canada) - 2/9/2018 9:10:00 AM
Salix Provides Update on FDA Submission for PLENVU®* PR Newswire (US) - 2/9/2018 9:10:00 AM
Investment Opportunities in Advanced Bioengineered Drug Delivery NetworkNewsWire - 2/7/2018 8:45:00 AM
Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28 PR Newswire (Canada) - 2/6/2018 10:25:00 AM
Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28 PR Newswire (US) - 2/6/2018 10:25:00 AM
VRX Investor Alert: Kyros Law Files Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors PR Newswire (US) - 1/30/2018 7:05:00 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 1/29/2018 10:33:33 AM
Valeant Will Reduce Debt By An Additional $200 Million PR Newswire (Canada) - 1/25/2018 3:02:00 PM
Valeant Will Reduce Debt By An Additional $200 Million PR Newswire (US) - 1/25/2018 3:02:00 PM
Allergan Pact Advances -- WSJ Dow Jones News - 1/17/2018 3:02:00 AM
Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant -- Update Dow Jones News - 1/16/2018 6:32:00 PM
Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and Pershing, Valeant Dow Jones News - 1/16/2018 5:09:00 PM
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form PR Newswire (Canada) - 1/12/2018 7:00:00 AM
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form PR Newswire (US) - 1/12/2018 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/9/2018 3:31:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/9/2018 3:28:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/9/2018 3:26:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/9/2018 10:05:55 AM
Valeant Provides Company Update At The 36th Annual J.P. Morgan Healthcare Conference PR Newswire (Canada) - 1/9/2018 7:00:00 AM
Valeant Provides Company Update At The 36th Annual J.P. Morgan Healthcare Conference PR Newswire (US) - 1/9/2018 7:00:00 AM
Bausch + Lomb Receives CE Mark From The European Commission For The Stellaris Elite™ Vision Enhancement System, Including T... PR Newswire (US) - 1/8/2018 8:00:00 AM
Bausch + Lomb Receives CE Mark From The European Commission For The Stellaris Elite™ Vision Enhancement System, Including T... PR Newswire (Canada) - 1/8/2018 8:00:00 AM
JLS   Friday, 11/10/17 01:10:42 PM
Re: ChrisJP post# 3885
Post # of 4362 
Agree, it's not orderly,

but Market Makers make their money off the Spread (the difference between Bid and Ask). MMs don't care if the stock goes up or down. But they do care if there is frantic buying and selling by investors, and the MMs react to that by increasing the difference between Bid and Ask (as they should because the market is being more unpredictable, AKA higher volatility).

Nervous Nellies (average Joe traders) see the stock go down right away in the morning, so they get nervous and sell. IMHO, that's how to interpret the intraday opening. Cooler heads know better than to do that.

In the chart below is a chart I've had for a few days. The horizontal channel defined by green dashed lines is the range that I expect VRX to trade within for the near future. If VRX decides to carve out a new channel (whether flat or not) I will use that pattern to determine future trades (which means that as VRX shows signs of respecting overhead resistance I will be keeping the stock and selling Covered Calls on it to derive additional income). Those Calls will usually be chosen to expire withing one or two weeks. If my shares get assigned, I'll choose my price according to trading patterns within that channel to go back in (long the stock) and repeat. Or sometimes I'll roll the Calls out to the next expiration so that the shares don't get assigned.

Sometimes I refer to this Call-selling process as paying my own dividends.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist